http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105839172-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C30B29-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C30B7-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C30B7-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C30B29-10
filingDate 2016-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105839172-B
titleOfInvention A kind of monoclinic phase BiVO4/ GO/RGO crystal and preparation method thereof
abstract The invention discloses a kind of monoclinic phase BiVO 4 / GO/RGO crystal and preparation method thereof, with Bi (NO 3 ) 3 ยท5H 2 O is the sources Bi, sequentially adds oleic acid, normal heptane, acetone thereto, stirs 6 10h, synthetic fibers shape Bi at low temperature 2 O 3 Template.The Bi that will be made 2 O 3 Template and NH 4 VO 3 It is dissolved in ethyl alcohol and aqueous solution, is mixed after dissolving respectively, add scattered GO suspensions, form precursor liquid, BiVO is made in 180 DEG C of hydro-thermal reactions in precursor liquid 4 / GO/RGO crystal.Wherein BiVO 4 For monoclinic phase, space structure group is I2/a (15), and with the extension of hydro-thermal time, crystal development is more complete, has the better structural stability.GO is partially reduced in hydrothermal reaction process, and with the extension of time, the degree that is reduced of GO is bigger.This method is easy to operate, process stabilizing, is a kind of preparation method of mature and feasible.
priorityDate 2016-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453530231
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6547
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414859283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10130092
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453492911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449766399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456986878
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID516875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297

Total number of triples: 36.